The Role of Clinical Pathways in Reducing the Economic Burden of Stroke

Author： Lanska D.J.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.14, Iss.2, 1998-08, pp. : 151-158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Clinical Update and Global Economic Burden of Rheumatoid Arthritis

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 18, Iss. 2, 2018-02 ,pp. : 98-109

Bentham Science Publishers

Access to resources Recommend Favorite

Reducing the Societal Burden of Depression: A Review of Economic Costs, Quality of Care and Effects of Treatment

By Donohue Julie M.   Harold Alan Pincus  

PharmacoEconomics, Vol. 25, Iss. 1, 2007-01 ,pp. : 7-24

Adis International

Access to resources Recommend Favorite

The Large and Growing Burden of Stroke

By  

Current Drug Targets, Vol. 8, Iss. 7, 2007-07 ,pp. : 786-793

Bentham Science Publishers

Access to resources Recommend Favorite

Economic burden of osteoarthritis in the US

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 596, 2010-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

The Economic Burden of Migraine to Society

By Ferrari M.D.  

PharmacoEconomics, Vol. 13, Iss. 6, 1998-06 ,pp. : 667-676

Adis International

Access to resources Recommend Favorite